Project Grant HT94252510533
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$681K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
The federal Project Grant award of $2,013,978.00 to New York University School of Medicine was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation." The research aims to investigate innovative approaches to disease prevention, diagnosis, treatment, and management, with a...
This $254,153 federal Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at New York University (NYU) School of Medicine. The award period is from March 1, 2025 to February 28, 2027. The grant will fund research to investigate the relationship between microplastics and prostate cancer. As a leading academic medical institution, NYU School of Medicine will...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,947 Project Grant to New York University (NYU) School of Medicine on September 15, 2024. The grant supports a 3-year research project titled "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." This funding enables NYU's research team to investigate the genomic and molecular impacts of benzene exposure, with the goal of advancing scientific...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $975,210.00 to New York University (NYU) School of Medicine to conduct research on the "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure". The award period runs from September 15, 2024 to September 14, 2027. Through this funding, NYU School of Medicine will carry out innovative biomedical research investigating the genetic and...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
This federal Project Grant award of $2,278,276.00 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will fund research by New York University (NYU) to optimize psychological health and prevent clinical problems. The three-year project will test the effectiveness of an evidence-based toolkit for integrated operational support. NYU has extensive experience conducting federal grant-funded research across a range of domains,...
The New York University will receive $936,199 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this three-year award beginning September 2022, New York University researchers will investigate receptors in endosomes that mediate chronic pain associated with trauma,...
This $749,343 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by New York University School of Medicine on a "PEPTIDE TREATMENT FOR CARTILAGE INJURIES AND POST-TRAUMATIC OSTEOARTHRITIS". The award period runs from August 1, 2025 to July 31, 2027 and aims to develop innovative approaches to prevent, diagnose, and treat medical conditions relevant to military...
This Project Grant from the Department of the Army Medical Command provides $663,465 to New York University School of Medicine for research titled "Early Determinants of Melanoma Metastasis." The award period is from July 15, 2021 through July 14, 2024. The funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research. Specifically, the grant will fund New York...